:: Altroz - News Magazine HTML Template ::

Language:

Spikevax News

Moderna Faces $1 Billion Net Loss in Q1 2025 Amid Declining COVID-19 Vaccine Sales

James Carter 01 May, 2025

Moderna reports a $1 billion net loss in Q1 2025 due to decreased COVID-19 vaccine sales, with Spikevax® generating $84 million. CEO Stephane Bancel remains optimistic about future...

Spikevax News

Moderna Faces $1 Billion Net Loss in Q1 2025 Amid Declining COVID-19 Vaccine Sales

Popular News

Swiss Inflation Dips Slightly to 0.3% in February: A Closer Look at Consumer Prices

Air India Eyes Massive Fleet Expansion with 30-40 New Wide-Body Jets from Airbus and Boeing

Crude Oil Prices Dip Over 1% Amid China-US Tariff Tensions and Global Trade Uncertainties

South Korea's Job Market Faces Polarization as Manufacturing Jobs Plummet to Six-Year Low

Rupee Set to Surpass 86 Against Dollar: RBI Governor's First Major Test

Asia-Pacific Markets Dip as Trade Uncertainties Loom Over Investors

Mexico Challenges US Steel and Aluminum Tariffs: A Strategic Move by President Sheinbaum

India Aims to Become the Global Leader in Supplying Skilled Manpower

Newsletter

Subscribe Newsletter!

Privacy Policy

Terms & Conditions

Contact Us